Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Stirrups

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|May 1, 2019
Idelalisib and rituximab for chronic lymphocytic leukaemiaRobert Stirrups
The Lancet. Oncology|July 2, 2019
Lapatinib with chemotherapy for gastro-oesophageal cancerRobert Stirrups
The Lancet. Oncology|March 9, 2020
Pembrolizumab for triple-negative breast cancerRobert Stirrups
The Lancet. Oncology|December 5, 2018
Surveillance imaging of Wilms' tumoursRobert Stirrups
The Lancet. Oncology|January 27, 2020
Dasatinib versus imatinib for childhood acute lymphocytic leukaemiaRobert Stirrups
The Lancet. Oncology|November 28, 2017
Osimertinib improves progression-free survival in NSCLCRobert Stirrups
The Lancet. Neurology|June 15, 2024
Changing the culture around dementiaRobert Stirrups
The Lancet. Oncology|March 5, 2019
Sacituzumab govitecan-hziy for triple-negative breast cancerRobert Stirrups
The Lancet. Oncology|March 27, 2019
Neratinib and capecitabine for breast cancer brain metastasesRobert Stirrups
The Lancet. Neurology|June 17, 2026
Balancing awareness and empathy in Tourette's syndromeRobert Stirrups
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|May 1, 2019
Idelalisib and rituximab for chronic lymphocytic leukaemiaRobert Stirrups
The Lancet. Oncology|July 2, 2019
Lapatinib with chemotherapy for gastro-oesophageal cancerRobert Stirrups
The Lancet. Oncology|March 9, 2020
Pembrolizumab for triple-negative breast cancerRobert Stirrups
The Lancet. Oncology|December 5, 2018
Surveillance imaging of Wilms' tumoursRobert Stirrups
The Lancet. Oncology|January 27, 2020
Dasatinib versus imatinib for childhood acute lymphocytic leukaemiaRobert Stirrups
The Lancet. Oncology|November 28, 2017
Osimertinib improves progression-free survival in NSCLCRobert Stirrups
The Lancet. Neurology|June 15, 2024
Changing the culture around dementiaRobert Stirrups
The Lancet. Oncology|March 5, 2019
Sacituzumab govitecan-hziy for triple-negative breast cancerRobert Stirrups
The Lancet. Oncology|March 27, 2019
Neratinib and capecitabine for breast cancer brain metastasesRobert Stirrups
The Lancet. Neurology|June 17, 2026
Balancing awareness and empathy in Tourette's syndromeRobert Stirrups
Pageof 5